Defining the burden of respiratory syncytial virus infection.
Department of Pediatrics, Division of Infectious Diseases, Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH, United States. Electronic address: Asuncion.mejias@nationwidechildrens.org.
Asuncion
A
Mejias
Octavio
O
Ramilo
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D017281:Cost of Illness; D006801:Humans; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D012136:Respiratory Syncytial Viruses; D012307:Risk Factors; D012621:Seasons
D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab